Giulia pasello

An audit of the biomarkers ATLAS project (biomarkersatlas.com) is available @LungCaJournal. A knowledge-based database integrating clinical and molecular records from 80 referral Italian institutions led by Dr. @UmbertoMalapel1. lungcancerjournal.info/article/S0169-…

@giuliapasello @JessicaJLinMD @peters_solange discussing resistance in targeted therapies, sequencing, toxgmt, development of nextgen tx options in biomarker driven NSCLC #ELCC24 #lcsm #alk

🏅🎖️This year, the best poster of the category NSCLC METASTATIC #ESMO2023 goes to Thiago Madeira @ThiagoMadeiraa and his mentor @MaysaVilbert exploring RW neurocognitive AEs related to lorlatinib in ALK and ROS + NSCLC. Congratulations!!!

We love our #ASCO23 host @marinagarassino! @EnriquetaFelip @peters_solange @delvysra @HendriksLizza @HwakeleeMD @PrelajArsela @ClaudiaProto @rossana_berardi @giuliapasello @LuisPaz_Ares @MartinReck2 @NReguart @a_dingemans @ChristianRolfo @JustinGainor @dplanchard @charocampelo

Starting the second day of the @iov_irccs Retreat! Sharing science for the benefit of our patients @valeguarneri @FedeMiglietta @giuliapasello

Adjuvant therapy session at #RomeLung22 highlights include Dr. Yi Long Wu discussing adjuvant #EGFR therapy, Dr. @EnriquetaFelip reviewing atezolizumab, Dr. @giuliapasello on canakinumab, and Dr. Simon Ekman on other checkpoint inhibitors. Important to choose the right path!

I Venerdì di AIRO: webinar su nuove evidenze e temi scottanti in radio-oncologia toracica nel trattamento del NSCLC stadio III 8 aprile 14.30-16.30 ecm.radioterapiaitalia.it/front/single/22 @AndrearicFili @PaoloBorghetti2 @ALESSIOBRUNI10 @giuliapasello @serenabadellino @stefanovagge @airo_young

#w4oitaly #women4oncology la slide presentata da LLicitra che ha caratterizzato un momento topico della sua carriera

First day, #W4Oitaly: crowded room, enthusiastic participation #women4onco@GarassinoMarina @grikamartinelli @myESMO

Primo corso di #w4oitaly. Due giorni, 50 oncologhe e tanto entusiasmo! @marinagarassino @grikamartinelli @myESMO

Body language session right now at #w4oitaly bit.ly/1RQGqOr #women4onco twitter.com/dontgetcaught/…

#women4onco #w4oitaly

Looking at the dark side is the best way to shed light on the evidence

#ASCO15 Brividi in plenaria: combinazione magica di nivolumab e ipilimumab per il trattamento del melanoma avanzato tinyurl.com/opdp85q

Discussing Child’s Cancer Prognosis Beneficial for Parents ow.ly/NGeIb #pedcsm #ASCO15

Il sorpasso è compiuto: il tumore del polmone prima causa di morte oncologica anche nelle ... tinyurl.com/l7tgcs5

Good night from #space. Buona notte dallo spazio.